Donor-specific antibodies present at the time of kidney transplantation in immunologically unmodified patients increase the risk of acute rejection
- 1 July 2016
- journal article
- Published by Elsevier in Transplant Immunology
- Vol. 37, 18-22
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Rates and Determinants of Progression to Graft Failure in Kidney Allograft Recipients With De Novo Donor-Specific AntibodyAmerican Journal of Transplantation, 2015
- Kidney Transplantation in Immunologically High-Risk PatientsTransplantation Proceedings, 2013
- Microcirculation Inflammation Associates With Outcome in Renal Transplant Patients With De Novo Donor-Specific AntibodiesAmerican Journal of Transplantation, 2012
- De Novo DQ Donor-Specific Antibodies Are Associated With a Significant Risk of Antibody-Mediated Rejection and Transplant GlomerulopathyTransplantation, 2012
- C4d-Fixing Capability of Low-Level Donor-Specific HLA Antibodies Is Not Predictive for Early Antibody-Mediated RejectionTransplantation, 2010
- Transplant Glomerulopathy: Risk and Prognosis Related to Anti-Human Leukocyte Antigen Class II Antibody LevelsTransplantation, 2008
- Transplant Glomerulopathy: Subclinical Incidence and Association with AlloantibodyAmerican Journal of Transplantation, 2007
- Kidney Transplantation in Patients with Antibodies against Donor HLA Class IIAmerican Journal of Transplantation, 2007
- Renal graft survival is not influenced by a positive flow B‐cell crossmatchClinical Transplantation, 2007
- LONG-TERM GRAFT SURVIVAL IS IMPROVED IN CADAVERIC RENAL RETRANSPLANTATION BY FLOW CYTOMETRIC CROSSMATCHING1Transplantation, 1998